FibroGen Archives -

After FDA snub, EMA backs FibroGen, Astellas’ roxadustat

https://pharmaphorum.com/news/after-fda-snub-ema-backs-fibrogen-astellas-roxadustat/

FDA rejects FibroGen/AZ’s roxadustat, asking for new trial

https://pharmaphorum.com/news/fda-rejects-fibrogen-azs-roxadustat-asking-for-new-trial/

FDA adcomm turns down FibroGen, AZ’s roxadustat for CKD anaemia

https://pharmaphorum.com/news/fda-adcomm-turns-down-fibrogen-azs-roxadustat-for-ckd-anaemia/

GSK’s kidney disease anaemia drug approved in Japan, taking on Astellas’ rival

https://pharmaphorum.com/news/gsk-kidney-disease-anaemia-drug-approved-in-japan-taking-on-astellas-rival/

AZ preps for US filing of kidney disease anaemia drug

https://pharmaphorum.com/news/az-preps-for-us-filing-of-kidney-disease-anaemia-drugs/

Astellas gets nod in Japan for roxadustat, ahead of GSK rival

https://pharmaphorum.com/news/astellas-gets-nod-in-japan-for-roxadustat-ahead-of-gsk-rival/

AstraZeneca shows cardiovascular safety for roxadustat

https://pharmaphorum.com/news/astrazeneca-shows-cardiovascular-safety-for-roxadustat/

Galapagos and FibroGen drugs offer hope in IPF

https://pharmaphorum.com/news/galapagos-fibrogen-ipf/

Search